Le Lézard
Classified in: Health
Subjects: SVY, MAT

Dr. David Samadi of RoboticOncology explains why Urolift is one of many options for BPH

NEW YORK, Nov. 26, 2019 /PRNewswire/ -- There comes a time in a man's life when urinary symptoms become a problem. Symptoms such as waking up several times a night to go, needing to find a men's room every time he's out, or difficulty urinating as if something is blocking the flow. Likely, these symptoms are from an enlarged prostate, a condition called benign prostatic hyperplasia or BPH. Usual treatments have included lifestyle changes, medications, and surgery with some success but also some side effects. That's why men with BPH should consider Urolift, a minimally invasive approach for treating BPH with long-term success.

David B. Samadi, MD, Urologic Oncology Expert and Robotic Surgeon

The dilemma of BPH

"As men age, their prostate can begin to grow compressing the urethra, blocking the passageway and preventing normal urine flow," explained Dr. David Samadi, Director of Men's Health at St. Francis Hospital in Roslyn, New York. "BPH is a progressive condition and is very common among older men.  In fact, over 40% of men in their 50's have BPH and this number increases to over 70% of men in their 60's.  The good thing to know is BPH has nothing to do with prostate cancer but can greatly affect a man's quality of life."

As the prostate grows, bothersome symptoms can appear such as:                                

"No man with BPH enjoys making multiple trips to the bathroom during the night affecting their sleep and relationships" said Dr. Samadi. "For a long time, options for treating BPH have been limited to lifestyle changes, medications or surgery."

"Giving advice on modifying behavior and lifestyle such as drinking fewer fluids before bedtime is somewhat helpful in the short term," exclaimed Dr. Samadi. "But it's also telling a man to learn to live with the symptoms. Unfortunately, over time symptoms can get worse and waiting now may make it harder to reduce symptoms later."

Prescription medications for BPH are another option but may have potential side effects such as headaches, dizziness, nasal congestion and loss of libido.  BPH drugs may not work for everyone or take several months to work and they require continual use to manage symptoms while becoming less effective over time.

"The third option is surgery to  remove part of the prostate ," said Dr. Samadi.  "While surgery can be an effective treatment for BPH, it may also mean longer Foley catheter placement, retrograde ejaculation and other issues.  

Why Urolift?

Urolift is a procedure addressing BPH relief right away.  Lifestyle changes, medications, and surgery take time to work if they bring relief. This treatment option can be used at earlier stages of BPH getting men off medications and avoiding major surgery.

"Men I've treated for BPH using Urolift experience immediate relief of symptoms helping them resume normal activities," stated Dr. David Samadi, Director of Men's Health at St. Francis Hospital in Roslyn, New York.    "When compared to medications or surgery, Urolift significantly improves quality of life for men. It's safe, effective and even better, men will be happy to know it doesn't cause as much retrograde ejaculation as TURP."

Urolift was approved by the Food and Drug Administration (FDA) in 2013.  It's typically performed as a one-time outpatient solution providing rapid relief and fast recovery.

"The Urolift system uses tiny implants to hold open the pathway obstructed by an enlarged prostate preventing blockage of urine flow," explained Dr. Samadi. "Approval of Urolift has proved to be a game changer for men who suffer from BPH. Men say they notice results on the same day as the procedure and over time, symptoms of BPH get better. That's fast relief."

Dr. Samadi also added, "The procedure takes about 20 minutes.  Afterwards, most men no longer need BPH medications and by avoiding surgery, they avoid surgical destruction of tissue taking a longer time to heal. Plus, five years of clinical data on hundreds of patients have shown consistent results and relief from symptoms of BPH."  Of course there is no guarantee that it would for everyone.

"Men with BPH deserve better treatment options freeing them from the discomforts of BPH," stated Dr. Samadi. "Men with BPH should ask their doctor if they're a good candidate for Urolift.  It's likely their best solution for taking back their urinary functioning and life."

David B. Samadi, MD, Urologic Oncology Expert and Robotic Surgeon located at 485 Madison Avenue on the 21st floor, New York, NY ? 212-365-5000.  Follow Dr. Samadi at www.samadimd.comwww.prostatecancer911.com, and www.roboticoncology.com.

CONTACT: Dr. David Samadi, robotmd@yahoo.com

SOURCE RoboticOncology

These press releases may also interest you

at 00:00
The American Mission Hospital (AMH) has partnered up with Soza Health UK and Dhu3 to conduct health assessments in Bahrain. Under the theme 'Wellness in the workplace' ? Protecting your employees' it has launched the SOZA Health 'pilot' assessment...

at 00:00
With years of feedback from Orthopedics, Neurosurgeons, and Interventional pain physicians, Sacrix has developed the third iteration of the SacroFuse threaded compression device for immediate stabilization of the sacroiliac joint for pain relief and...

23 jan 2021
Despite concerns about both the COVID pandemic and political unrest, San Francisco pro-lifers held the 17th Annual Walk for Life West Coast today. Organizers had expected hundreds of attendees; thousands showed up. Walk co-chair Eva Muntean was...

23 jan 2021
The CEO of InterMed Resources TN, Roger Biles, adjusted his company's business structure in order to meet the exponential demands of personal protective equipment (PPE)....

23 jan 2021
The U.S. Small Business Administration (SBA) announced that Raptamer Discovery Group is one of only 38 companies, seven organizations and 14 individuals in the country to receive the prestigious Tibbetts Award for their accomplishments in creating...

23 jan 2021
eMedtm, a digital health company democratizing healthcare through digital point-of-care solutions, announced it will begin to administer the FDA-authorized, at-home symptomatic BinaxNOWtm COVID-19 Ag Card rapid home test to 100,000 qualified...

News published on 26 november 2019 at 08:05 and distributed by: